COVID-19 Basic Research
Pedram S Jahani
Characterized the lung immune cells for COVID-19 and are now measuring human serum to establish immunity.
Study the immune landscape of patients with COVID-19.
Study of T Cell Repertoire Changes in SARS-COV-2 (COVID-19) Infected Subjects
Effects of maternal COVID-19 infection on blood placenta barrier integrity.
Studying stem cells and exosomes for moderate-severe COVID-19 respiratory distress syndrome.
Providing non-infectious models of viral entry into cells for antibody screening.
Structural basis of SARS-CoV-2 entry in the host cell
Kwang Jin Kim
Wei Ming Yuan
Studying exposure to COVID-19 proteins on lung cell function.
Deactivation of Airborne and Surface-Borne Viruses using Nanosecond Pulsed Plasmas
Mapping SARS-CoV-2-induced metabolic changes in lung alveolar epithelial cells and macrophages
Understanding the role of COVID19 in insulin cell dysfunction and the pathogenesis of diabetes
Identifying and characterizing how COVID-19 enters human host cells.
CEACAM proteins as New Cellular Receptors for SARS-Cov-2
Clinical outcomes, viral shedding and development of immune responses in mother-infant pairs affected by COVID-19.
J. Perren Cobb
Delirium in critically ill patients with SARS-CoV-2 infection.
Adapting sequence-based HIV platform for phylogenetic analysis of COVID-19 virus.
SARS-CoV-2 whole genome sequencing and transmission cluster identification for COVID-19 genomic surveillance
Studying mechanisms of virus entry and egress to identify new methods for virus prevention via blocking transmission.
Studying inhibition of COVID virus receptors for drug treatments.
Identification of specific COVID-19 mutations at different stages of lung disease.
Classification of COVID-19 viral genome sequences in relation to disease severity.
Developed a pipeline to monitor genome-wide translation in live cells to, aiding the study of interactions between the virus and its human host.
Constructing SARS virus proteins, developing high affinity binding reagents to these proteins, and deploying these reagents in serological assays to measure both viral proteins in biological fluids and the host antibody responses to infections. More here and here.
Identifying molecular markers of severe outcome susceptibility for COVID-19.
RAPID: Probing SARS-CoV-2 evolution and vulnerabilities through its mutation and fitness landscape
Studying secondary bacterial infections in patients hospitalized for COVID-19.
Identifying SARS-CoV-2 virus genes responsible for disregulating human immune responses.
Suppression of NKT cell function by SARS-CoV-2 virus
Discovering inhibitors of coronavirus protein.